减重手术后药物中毒:病例系列报告
该研究利用国家药物使用死亡项目数据,识别出18例曾接受减重手术的死亡病例。几乎所有病例检出阿片类药物且常被认定与死亡相关,每例尸检均检出多种药物且常包括未处方药物,三分之一死亡被判定为自杀,提示减重术后患者对处方药危害存在独特脆弱性。
要点
- 减重术后死亡病例中阿片类药物几乎普遍检出且常与死亡相关。
- 每例尸检均检出多种药物,常包括死者未主动处方药物。
- 三分之一死亡被判定为自杀,需关注术后心理健康与处方药安全。
核心结论
- 减重术后患者对处方药物危害存在独特脆弱性,亟需理解手术对药代动力学的影响并加强多学科术后照护、治疗药物监测和用药安全教育。
研究设计与样本
- 基于国家药物使用死亡项目报告数据的病例系列,共识别18例曾接受减重手术的死亡病例。
主要发现
- 几乎所有病例检出阿片类药物,且阿片类药物常被认定与死亡相关。
- 每例尸检均检出多种药物,且常包括死者未主动处方的药物。
- 精神健康状况和慢性疼痛是常见合并症,三分之一死亡被判定为自杀。
- 非法药物和酒精使用少见。
临床怎么用
- 对减重术后患者应开展多学科整合术后照护,关注处方药尤其阿片类药物的安全使用。
- 考虑对减重术后患者进行治疗药物监测并开展针对性用药安全教育。
局限性
- 原文未报告样本量以外的详细统计指标,且为病例系列报告,未设对照。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Bariatric surgery alters gastrointestinal anatomy and physiology, which likely impacts upon oral medication absorption. Drug- and alcohol-related deaths in this population are being increasingly reported; however, toxicological detail is lacking. Using data reported to the National Programme on Substance Use Mortality, we identified 18 deaths in people who had previously undergone bariatric surgery. Opioids were detected in almost all cases and were frequently implicated in causing death. Multiple medications were detected at post-mortem in every case and often included medications that the deceased was not actively prescribed. Mental health conditions and chronic pain were commonly listed comorbidities and one-third of deaths were deemed suicide. Illicit drug and alcohol use was rare, highlighting a distinct vulnerability to prescription medication harms. Our findings emphasize a need to understand how bariatric surgery alters pharmacokinetics and for integrated, multidisciplinary aftercare, therapeutic drug monitoring and tailored education of safe medication use in bariatric surgery patients.
引用
- Mshari E, LaJeunesse-Trempe F, Morley S, et al. Drug poisonings following bariatric surgery: Case series report. Br J Clin Pharmacol. 2025. PMID: 41397440. doi:10.1002/bcp.70387
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。